ProMIS Neurosciences Inc is a biotech company. It is engaged in discovering and developing precision medicine therapeutics for the effective treatment of neurodegenerative diseases, in particular, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD).
Copying Thomas Shrader's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.35% per trade.